The Accreditation Council for Continuing Medical Education (ACCME) offers a helpful tip for those seeking to fulfill Standard 3 of their accreditation requirements.

In an effort to boost pathologists' skills in scoring breast cancer stromal tumor-infiltrating lymphocytes (TILs), experts from the Food and Drug Administration (FDA) teamed up with academic pathologists to develop a continuing medical education (CME) course on the topic.

A work group brought together by the Accreditation Council for Graduate Medical Education, Accreditation Council for Continuing Medical Education, Association of American Medical Colleges and American Association of Colleges of Osteopathic Medicine in 2020 developed the Clinician Educator Milestones (CEMs).

This series and its authors received the Almanac Author of the Year Award at the Alliance 2024 Annual Conference. Read the full series: Part 1, Part 2, Part 3 and Part 4.

A lawsuit against the Medical Board of California challenges its mandatory implicit bias training for physicians.